Publications by authors named "Maria A Guerra"
Article Synopsis
- Diabetes is a common disease globally, with rising rates of acute complications like hyperglycemic crises, characterized by features of diabetic ketoacidosis and hyperosmolar state.
- A study conducted at Fundación Valle del Lili from 2015 to 2020 analyzed 317 cases of hyperglycemic crises, revealing that most patients had a combined state of both ketoacidosis and hyperosmolarity, often triggered by infections.
- The findings showed a mortality rate similar for both conditions, with invasive mechanical ventilation significantly associated with increased death rates among these patients.
Clinical Experience of Using Telemedicine for the Management of Patients Using Continuous Subcutaneous Insulin Infusion in a Highly Complex Latin American Hospital.
Int J Environ Res Public Health
May 2023
Introduction: Continuous subcutaneous insulin infusion (CSII) has emerged as a potential solution for diabetes management during the pandemic, as it reduces the need for in-person visits and allows for remote monitoring of patients. Telemedicine has also become increasingly important in the management of diabetes during the pandemic, as it allows healthcare providers to provide remote consultations and support. Here, we discuss the implications of this approach for diabetes management beyond the pandemic, including the potential for increased access to care and improved patient outcomes.
View Article and Find Full Text PDFBackground: Maturity-onset diabetes of the young comprises a large group of autosomal inherited gene mutations. Maturity-onset diabetes of the young subtype 5 is caused by mutations in the HNF1B gene. This gene is expressed in the early phase of embryonic development in the pancreas, kidneys, liver, and genital tract; therefore, kidney or urinary tract malformations are associated with diabetes mellitus.
View Article and Find Full Text PDFBackground: Respiratory recurrent papillomatosis (RRP) is a fatal disease with no known cure. In severe RRP cases, systemic bevacizumab (SB) could be used as adjuvant therapy.
Objective: This study aims to determine the extent and type of evidence in relation to the clinical outcomes of RRP after SB treatment.
Systemic lupus erythematosus (SLE) is an autoimmune disease with heterogeneous pathophysiologic mechanisms and diverse clinical manifestations. SLE is a frequent cause of intensive care unit (ICU) admissions. Multiple studies with controversial findings on the causes, evolution and outcomes of ICU-admitted patients with SLE have been published.
View Article and Find Full Text PDFObjective: Systemic lupus erythematosus (SLE) is a clinically heterogeneous autoimmune disease, and in some conditions, admission to the intensive care unit (ICUs) is required. This study describes the clinical and prognostic factors in SLE patients admitted to the ICU.
Methods: We conducted a retrospective study that reviewed all clinical records of patients with SLE admitted to the ICU between 2011 and 2018.